Cargando…
Comparative Study on the Efficacy and Safety of Tumor Resection in Vitrectomy for Retinal Vasoproliferative Tumors
PURPOSE: To investigate the efficacy and safety of combined vitrectomy with tumor resection in the treatment of retinal vasoproliferative tumors (RVPT). METHODS: Retrospective study. RVPT patients who underwent vitreous surgery at the Eye Hospital of Wenzhou Medical University from January 2011 to J...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334322/ https://www.ncbi.nlm.nih.gov/pubmed/30719338 http://dx.doi.org/10.1155/2019/7464123 |
_version_ | 1783387687380582400 |
---|---|
author | Zheng, Bin Chen, Yan Chen, Lifeng Chen, Huan Zheng, Jingwei Chen, Feng Song, Zongming Fu, Lin Hu, Xuting Pan, Jiandong Lian, Hengli Shen, Lijun Li, Qiuming |
author_facet | Zheng, Bin Chen, Yan Chen, Lifeng Chen, Huan Zheng, Jingwei Chen, Feng Song, Zongming Fu, Lin Hu, Xuting Pan, Jiandong Lian, Hengli Shen, Lijun Li, Qiuming |
author_sort | Zheng, Bin |
collection | PubMed |
description | PURPOSE: To investigate the efficacy and safety of combined vitrectomy with tumor resection in the treatment of retinal vasoproliferative tumors (RVPT). METHODS: Retrospective study. RVPT patients who underwent vitreous surgery at the Eye Hospital of Wenzhou Medical University from January 2011 to July 2017 were included. The main outcomes included treatment type, tumor activity, and best-corrected visual acuity (BCVA). RESULTS: Altogether, 16 patients with 17 eyes were enrolled with follow-up of no less than 6 months. Eight eyes were in the resection treatment group (Group R) and 9 eyes were in the conservative treatment group (Group C). Female (69%) were more common. The mean age was 50 (49.72 ± 12.92) years. Fifteen patients got unilateral onset and only one patient suffered bilaterally. The common symptoms were decreased visual acuity, floaters, and visual distortion. The preoperative BCVA ranged from hand movement to 20/20, with an average of 0.82 ± 0.75 LogMAR. Patients were all not high myopia, with a mean axial length of 23.27 ± 0.27 mm (21.61 mm to 24.67 mm). Of the retinal diseases, the epiretinal membrane was the most common, followed by vitreous hemorrhage, uveitis, subretinal fluid, and so on. Compared with the baseline BCVA, it improved more at postoperative 6 months and the last visit in Group R than in Group C (P=0.006 and P=0.033). The BCVA-improved 0.2 LogMAR or above in 6 months was 2 eyes in Group C and 7 eyes in Group R. All tumors in Group R were completely resected, whereas three in Group C (33.3%) had definite activity (P=0.008). In all samples, tumors were located on the inner side of the retina and had small vessel wall thickening and hyaline degeneration. The degree of astrocyte proliferation varies widely among different tumors. CONCLUSIONS: RVPT was more likely to occur in nonhigh myopia patients. Epiretinal membrane and vitreous hemorrhage were the main causes for vitreous surgery in RVPT patients. Compared with conservative treatment, surgical resection of the tumor is more beneficial to patients on visual acuity recovery and preventing tumor relapse. It is a safe and effective way to treat RVPT. |
format | Online Article Text |
id | pubmed-6334322 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-63343222019-02-04 Comparative Study on the Efficacy and Safety of Tumor Resection in Vitrectomy for Retinal Vasoproliferative Tumors Zheng, Bin Chen, Yan Chen, Lifeng Chen, Huan Zheng, Jingwei Chen, Feng Song, Zongming Fu, Lin Hu, Xuting Pan, Jiandong Lian, Hengli Shen, Lijun Li, Qiuming J Ophthalmol Research Article PURPOSE: To investigate the efficacy and safety of combined vitrectomy with tumor resection in the treatment of retinal vasoproliferative tumors (RVPT). METHODS: Retrospective study. RVPT patients who underwent vitreous surgery at the Eye Hospital of Wenzhou Medical University from January 2011 to July 2017 were included. The main outcomes included treatment type, tumor activity, and best-corrected visual acuity (BCVA). RESULTS: Altogether, 16 patients with 17 eyes were enrolled with follow-up of no less than 6 months. Eight eyes were in the resection treatment group (Group R) and 9 eyes were in the conservative treatment group (Group C). Female (69%) were more common. The mean age was 50 (49.72 ± 12.92) years. Fifteen patients got unilateral onset and only one patient suffered bilaterally. The common symptoms were decreased visual acuity, floaters, and visual distortion. The preoperative BCVA ranged from hand movement to 20/20, with an average of 0.82 ± 0.75 LogMAR. Patients were all not high myopia, with a mean axial length of 23.27 ± 0.27 mm (21.61 mm to 24.67 mm). Of the retinal diseases, the epiretinal membrane was the most common, followed by vitreous hemorrhage, uveitis, subretinal fluid, and so on. Compared with the baseline BCVA, it improved more at postoperative 6 months and the last visit in Group R than in Group C (P=0.006 and P=0.033). The BCVA-improved 0.2 LogMAR or above in 6 months was 2 eyes in Group C and 7 eyes in Group R. All tumors in Group R were completely resected, whereas three in Group C (33.3%) had definite activity (P=0.008). In all samples, tumors were located on the inner side of the retina and had small vessel wall thickening and hyaline degeneration. The degree of astrocyte proliferation varies widely among different tumors. CONCLUSIONS: RVPT was more likely to occur in nonhigh myopia patients. Epiretinal membrane and vitreous hemorrhage were the main causes for vitreous surgery in RVPT patients. Compared with conservative treatment, surgical resection of the tumor is more beneficial to patients on visual acuity recovery and preventing tumor relapse. It is a safe and effective way to treat RVPT. Hindawi 2019-01-02 /pmc/articles/PMC6334322/ /pubmed/30719338 http://dx.doi.org/10.1155/2019/7464123 Text en Copyright © 2019 Bin Zheng et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Zheng, Bin Chen, Yan Chen, Lifeng Chen, Huan Zheng, Jingwei Chen, Feng Song, Zongming Fu, Lin Hu, Xuting Pan, Jiandong Lian, Hengli Shen, Lijun Li, Qiuming Comparative Study on the Efficacy and Safety of Tumor Resection in Vitrectomy for Retinal Vasoproliferative Tumors |
title | Comparative Study on the Efficacy and Safety of Tumor Resection in Vitrectomy for Retinal Vasoproliferative Tumors |
title_full | Comparative Study on the Efficacy and Safety of Tumor Resection in Vitrectomy for Retinal Vasoproliferative Tumors |
title_fullStr | Comparative Study on the Efficacy and Safety of Tumor Resection in Vitrectomy for Retinal Vasoproliferative Tumors |
title_full_unstemmed | Comparative Study on the Efficacy and Safety of Tumor Resection in Vitrectomy for Retinal Vasoproliferative Tumors |
title_short | Comparative Study on the Efficacy and Safety of Tumor Resection in Vitrectomy for Retinal Vasoproliferative Tumors |
title_sort | comparative study on the efficacy and safety of tumor resection in vitrectomy for retinal vasoproliferative tumors |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334322/ https://www.ncbi.nlm.nih.gov/pubmed/30719338 http://dx.doi.org/10.1155/2019/7464123 |
work_keys_str_mv | AT zhengbin comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors AT chenyan comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors AT chenlifeng comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors AT chenhuan comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors AT zhengjingwei comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors AT chenfeng comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors AT songzongming comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors AT fulin comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors AT huxuting comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors AT panjiandong comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors AT lianhengli comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors AT shenlijun comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors AT liqiuming comparativestudyontheefficacyandsafetyoftumorresectioninvitrectomyforretinalvasoproliferativetumors |